Failure of cefotaxime and meropenem to eradicate meningitis caused by an intermediately susceptible Streptococcus pneumoniae strain.
Vandecasteele
S J
SJ
Department of General Internal Medicine and Infectious Diseases, University Hospital of Leuven, Belgium. Stefaan.Vandecasteele@uz.kuleuven.ac.be
Verhaegen
J
J
Colaert
J
J
Van Caster
A
A
Devlieger
H
H
D002439:Cefotaxime / Q000008:administration & dosage; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008586:Meningitis, Pneumococcal / Q000175:diagnosis / Q000188:drug therapy*; D000077731:Meropenem; D008826:Microbial Sensitivity Tests; D012720:Severity of Illness Index; D013129:Spinal Puncture; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000302:isolation & purification; D013845:Thienamycins / Q000008:administration & dosage; D017211:Treatment Failure; D014640:Vancomycin / Q000627:therapeutic use*
D013845:Thienamycins; D014640:Vancomycin; D000077731:Meropenem; D002439:Cefotaxime